Status:
UNKNOWN
VIGIP-SEP2: Evaluation of the Impact of the Training of Patients by a Nurse on the Adverse Drug Reaction Reporting by RRMS Patient Via a Mobile Application: Randomized Real-life Study
Lead Sponsor:
University Hospital, Caen
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The patient's reporting of adverse drug reactions (ADRs) is recognized as being of interest for post-marketing safety monitoring, but is still underdeveloped in France, with an average lower than the ...
Eligibility Criteria
Inclusion
- more than 18 years
- multiple sclerosis in initiation with a DMT
- patient informed and who gave informed consent
Exclusion
- patient without mobile or tablet
Key Trial Info
Start Date :
January 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2021
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT04116424
Start Date
January 1 2020
End Date
April 1 2021
Last Update
October 4 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.